Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.91 USD | +0.29% | -13.52% | -38.58% |
Apr. 02 | Transcript : Altimmune, Inc. - Special Call | |
Mar. 27 | Altimmune Shares Slip Wednesday, After Reporting a Wider Q4 Net Loss and Dropping Prospective Treatment for Hepatitis B | MT |
Financials (USD)
Sales 2024 * | 35.71M | Sales 2025 * | 28.57M | Capitalization | 488M |
---|---|---|---|---|---|
Net income 2024 * | -61M | Net income 2025 * | -147M | EV / Sales 2024 * | 11.1 x |
Net cash position 2024 * | 91.94M | Net cash position 2025 * | 285M | EV / Sales 2025 * | 7.13 x |
P/E ratio 2024 * |
-7.4
x | P/E ratio 2025 * |
-4.94
x | Employees | 59 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.22% |
Latest transcript on Altimmune, Inc.
1 day | -2.13% | ||
1 week | -17.98% | ||
Current month | -32.32% | ||
1 month | -24.12% | ||
3 months | -36.14% | ||
6 months | +173.41% | ||
Current year | -38.76% |
Managers | Title | Age | Since |
---|---|---|---|
Vipin K. Garg
CEO | Chief Executive Officer | 67 | 18-11-29 |
Director of Finance/CFO | 66 | 21-12-30 | |
Anthony Blandin
CMP | Compliance Officer | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchel Sayare
CHM | Chairman | 76 | 10-03-31 |
Mack Gill
BRD | Director/Board Member | 72 | 04-07-31 |
Philip Hodges
BRD | Director/Board Member | 56 | 03-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 6.91 | +0.29% | 3 584 744 |
24-04-18 | 6.89 | -2.13% | 3,215,984 |
24-04-17 | 7.04 | -6.38% | 3,640,921 |
24-04-16 | 7.52 | -0.40% | 2,723,827 |
24-04-15 | 7.55 | -5.51% | 3,527,172 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.76% | 488M | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.78% | 21.66B | |
-18.35% | 20.77B | |
-8.79% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- ALT Stock